|
|
|
|
|
16.12.25 - 12:06
|
Organigram Reports Record Fourth Quarter and Fiscal 2025 Results (Business Wire)
|
|
|
Record annual revenue, adjusted EBITDA1, and international sales.
TORONTO--(BUSINESS WIRE)--Organigram Global Inc (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 recreational cannabis company by market share2, is pleased to announce record results for the fourth quarter and twelve months ended September 30, 2025 (“Q4 Fiscal 2025” or "Fiscal 2025"). All financial information in this press release is expressed in Canadian dollars ("$").
FOURTH QUARTER 2025 FINANCIAL HIGHLIGHTS
Gross Revenue: $123.3 million (+76% year-over-year).
Net Revenue: $80.1 million (+79% year-over-year).
Adjusted Gross Margin1: $30.6 million or 38%.
Adjusted EBITDA1: $9.8 million (+69% year-over-year).
FISCAL 2025 FINANCIAL HIGHLIGHTS
Gross Revenue: $403.0 million (+63% year-over-year).
Net Revenue: $259.2 million (+62% year-over-year).
Adjusted Gross Margin1: $91.0 million or 35%.
Adjusted EBITDA1: $21.9 million (+160% year-over-year).
FISCAL 2025 COMPANY HIGHLIGHTS
#1 Market S...
|
|
|
|
|
05.12.25 - 12:06
|
Organigram to Report Fourth Quarter Fiscal 2025 Results on December 16, 2025 (Business Wire)
|
|
|
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share1, announced today it will report earnings results for its fourth quarter fiscal 2025 ended September 30, 2025, on Tuesday, December 16, 2025, prior to market open.
The Company will host a conference call to discuss its results with details as follows:
Date: Tuesday, December 16, 2025
Time: 8:00 am Eastern Time
To register for the conference call, please use this link:
https://registrations.events/direct/Q4I9676638
To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call. After registering, a confirmation will be sent through email, including dial in details and unique conference call codes for entry. Registration is open through the live call.
To access the webcast:
https://events.q4inc.com/attendee/724034228Participants will receive their details via email.
A rep...
|
|
|
|
|
25.11.25 - 12:03
|
Organigram Announces Appointment of Chief Executive Officer (Business Wire)
|
|
|
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce that James Yamanaka, formerly Global Head of Strategy for British American Tobacco, has been appointed the Company's new Chief Executive Officer (CEO). Mr. Yamanaka is expected to assume the role effective on or about January 15, 2026. Mr. Yamanaka will also join the Company's board of directors when he assumes the role of Chief Executive Officer.
Mr. Yamanaka is a seasoned executive, having spent more than 20 years at British American Tobacco, with extensive experience in strategy and general management across Europe and Asia. His career is distinguished by a strong track record of creating value-driven strategies, transforming businesses, and delivering outstanding commercial results.
As Global Head of Strategy at BAT, Mr. Yamanaka was instrumental in developing the Group strategy. Prior...
|
|
|
|
|
21.10.25 - 12:06
|
Organigram Global Announces Update to CEO Succession Plan (Business Wire)
|
|
|
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (“Organigram” or the “Company”) announces that Ms. Beena Goldenberg will extend her tenure as Chief Executive Officer until November 30, 2025 to support the completion of the Company's ongoing CEO search process.
The Board's search has attracted strong interest and they are pleased with the progress as they focus on identifying a leader aligned with Organigram's strategic vision and growth objectives. Beena will continue to lead day-to-day operations, ensuring continuity of execution and momentum across all business lines. The Company remains focused on delivering against its key priorities and creating long-term value for shareholders.
About Organigram
Organigram Global Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include Organigram Inc., a licensed cultivator and processor of cannabis and manufacturer of cannabis-derived goods in Canada. Through its recent acquisition of Collective Project Limited...
|
|
|
|
|
13.08.25 - 12:03
|
Organigram Reports Record Third Quarter Fiscal 2025 Results (Business Wire)
|
|
|
Second consecutive quarter of record revenue, strong adjusted EBITDA growth, Free Cash Flow, and continued international expansionTORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share1, is pleased to announce its record results for the third quarter ended June 30, 2025 (“Q3 Fiscal 2025” or “Q3”).
Q3 FISCAL 2025 HIGHLIGHTS
Record Gross Revenue: $110.2 million (+73% year-over-year, +7.2% sequential).
Record Net Revenue: $70.8 million (+72% year-over-year, +7.9% sequential).
International Revenue: $7.4 million (+208% year-over-year, +21% sequential).
Adjusted EBITDA2: $5.7 million (+64% year-over-year, +16% sequential).
Free Cash Flow2: $5.0 million versus ($4.8) million in the prior year period.
Motif Synergies: $4.2 million to date, approximately $11 million annualized; on track to hit $15 million target within 24 months of acquisition.
Total Cash: $85.9 million3, including $35.9 million of u...
|
|
|
|
|
01.08.25 - 12:06
|
Organigram to Report Third Quarter Fiscal 2025 Results on August 13, 2025 (Business Wire)
|
|
|
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, announced today it will report earnings results for its third quarter fiscal 2025 ended June 30, 2025, on Wednesday, August 13, 2025, prior to market open.
The Company will host a conference call to discuss its results with details as follows:
Date: Wednesday, August 13, 2025
Time: 8:00 am Eastern Time
To register for the conference call, please use this link:
https://registrations.events/direct/Q4I9676685
To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call. After registering, a confirmation will be sent through email, including dial in details and unique conference call codes for entry. Registration is open through the live call.
To access the webcast:
https://events.q4inc.com/attendee/755647987Participants will receive their details via email.
A replay of ...
|
|
|
|
|
|
|
|
|
27.05.25 - 12:06
|
Organigram Global Announces CEO Succession Plan (Business Wire)
|
|
|
Beena Goldenberg, CEO to retire at the end of the Company's fiscal year
Board of Directors expresses confidence in the Company's strategic direction and leadership team
Comprehensive CEO selection process will be initiated to identify a successor
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (“the Company” or “Organigram”), Canada's #1 cannabis company by market share, announced today that Ms. Beena Goldenberg, CEO, Organigram, will be retiring at the conclusion of the Company's current fiscal year ending September 30, 2025. Until this date, Ms. Goldenberg will continue in her role as CEO and as a member of the Company's Board of Directors (the “Board”) to advance Organigram's strategic objectives, including international expansion, and to ensure an effective transition.
Since joining Organigram as CEO in September 2021, Ms. Goldenberg successfully led the organization's growth and transformation from a cannabis company with $80M in net revenue to becoming t...
|
|
|
01.04.25 - 23:31
|
XFRA: NEW INSTRUMENT AVAILABLE - 02.04.2025 - CA68617J1003 (XETRA)
|
|
|
Das Instrument 0OG CA68617J1003 ORGANIGRAM GLOBAL INC. EQUITY hat seinen ersten Handelstag am 02.04.2025: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N
The instrument 0OG CA68617J1003 ORGANIGRAM GLOBAL INC. EQUITY has its first trading date on 02.04.2025: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N...
|
|
|
01.04.25 - 17:06
|
XFRA: ISIN Change (XETRA)
|
|
|
Einstellung Aufnahme
ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen
CA50203F2052 Skycap Investment Holdings Inc. 01.04.2025 CA83086W1023 Skycap Investment Holdings Inc. 02.04.2025 Tausch 1:1
CA29872T1003 Euro Manganese Inc. 01.04.2025 CA29872T2092 Euro Manganese Inc. 02.04.2025 Tausch 5:1
US98979Y1064 Zozo Inc. 01.04.2025 US98979Y2054 Zozo Inc. 02.04.2025 Tausch 5:3
CA68620P7056 Organigram Global Inc. 01.04.2025 CA68617J1003 Organigram Global Inc. 02.04.2025 Tausch 1:1...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
